These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34837245)

  • 21. Christmas-Related Reduction in Beta Activity in Parkinson's Disease.
    Feldmann LK; Lofredi R; Al-Fatly B; Busch JL; Mathiopoulou V; Roediger J; Krause P; Schneider GH; Faust K; Horn A; Kühn AA; Neumann WJ
    Mov Disord; 2023 Apr; 38(4):692-697. PubMed ID: 36718788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cortical Plasticity Induction by Pairing Subthalamic Nucleus Deep-Brain Stimulation and Primary Motor Cortical Transcranial Magnetic Stimulation in Parkinson's Disease.
    Udupa K; Bahl N; Ni Z; Gunraj C; Mazzella F; Moro E; Hodaie M; Lozano AM; Lang AE; Chen R
    J Neurosci; 2016 Jan; 36(2):396-404. PubMed ID: 26758832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Programming of subthalamic nucleus deep brain stimulation with hyperdirect pathway and corticospinal tract-guided parameter suggestions.
    Segura-Amil A; Nowacki A; Debove I; Petermann K; Tinkhauser G; Krack P; Pollo C; Nguyen TAK
    Hum Brain Mapp; 2023 Aug; 44(12):4439-4451. PubMed ID: 37318767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraoperative changes in the H-reflex pathway during deep brain stimulation surgery for Parkinson's disease: A potential biomarker for optimal electrode placement.
    Andrews JC; Roy FD; Ba F; Sankar T
    Brain Stimul; 2020; 13(6):1765-1773. PubMed ID: 33035725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rescuing Suboptimal Outcomes of Subthalamic Deep Brain Stimulation in Parkinson Disease by Surgical Lead Revision.
    Nickl RC; Reich MM; Pozzi NG; Fricke P; Lange F; Roothans J; Volkmann J; Matthies C
    Neurosurgery; 2019 Aug; 85(2):E314-E321. PubMed ID: 30839077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atlas-Independent, Electrophysiological Mapping of the Optimal Locus of Subthalamic Deep Brain Stimulation for the Motor Symptoms of Parkinson Disease.
    Conrad EC; Mossner JM; Chou KL; Patil PG
    Stereotact Funct Neurosurg; 2018; 96(2):91-99. PubMed ID: 29791914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-objective particle swarm optimization for postoperative deep brain stimulation targeting of subthalamic nucleus pathways.
    Peña E; Zhang S; Patriat R; Aman JE; Vitek JL; Harel N; Johnson MD
    J Neural Eng; 2018 Dec; 15(6):066020. PubMed ID: 30211697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyramidal tract activation due to subthalamic deep brain stimulation in Parkinson's disease.
    Mahlknecht P; Akram H; Georgiev D; Tripoliti E; Candelario J; Zacharia A; Zrinzo L; Hyam J; Hariz M; Foltynie T; Rothwell JC; Limousin P
    Mov Disord; 2017 Aug; 32(8):1174-1182. PubMed ID: 28590508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleaved programming of subthalamic deep brain stimulation to avoid adverse effects and preserve motor benefit in Parkinson's disease.
    Ramirez-Zamora A; Kahn M; Campbell J; DeLaCruz P; Pilitsis JG
    J Neurol; 2015 Mar; 262(3):578-84. PubMed ID: 25504447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes following awake and asleep deep brain stimulation for Parkinson disease.
    Chen T; Mirzadeh Z; Chapple KM; Lambert M; Shill HA; Moguel-Cobos G; Tröster AI; Dhall R; Ponce FA
    J Neurosurg; 2018 Mar; 130(1):109-120. PubMed ID: 29547091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Genetic Etiology of Parkinson's Disease Does Not Robustly Affect Subthalamic Physiology.
    Weill C; Gallant A; Baker Erdman H; Abu Snineh M; Linetsky E; Bergman H; Israel Z; Arkadir D
    Mov Disord; 2023 Mar; 38(3):484-489. PubMed ID: 36621944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Speech changes induced by deep brain stimulation of the subthalamic nucleus in Parkinson disease: involvement of the dentatorubrothalamic tract.
    Fenoy AJ; McHenry MA; Schiess MC
    J Neurosurg; 2017 Jun; 126(6):2017-2027. PubMed ID: 27611200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subthalamic nucleus stimulation in Parkinson's disease: postoperative CT-MRI fusion images confirm accuracy of electrode placement using intraoperative multi-unit recording.
    Shin M; Lefaucheur JP; Penholate MF; Brugières P; Gurruchaga JM; Nguyen JP
    Neurophysiol Clin; 2007 Dec; 37(6):457-66. PubMed ID: 18083502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease.
    Mueller K; Jech R; Růžička F; Holiga Š; Ballarini T; Bezdicek O; Möller HE; Vymazal J; Růžička E; Schroeter ML; Urgošík D
    Neuroimage Clin; 2018; 19():1025-1035. PubMed ID: 30035027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dominant efficiency of nonregular patterns of subthalamic nucleus deep brain stimulation for Parkinson's disease and obsessive-compulsive disorder in a data-driven computational model.
    Karamintziou SD; Deligiannis NG; Piallat B; Polosan M; Chabardès S; David O; Stathis PG; Tagaris GA; Boviatsis EJ; Sakas DE; Polychronaki GE; Tsirogiannis GL; Nikita KS
    J Neural Eng; 2016 Feb; 13(1):016013. PubMed ID: 26695534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short Versus Conventional Pulse-Width Deep Brain Stimulation in Parkinson's Disease: A Randomized Crossover Comparison.
    Dayal V; Grover T; Tripoliti E; Milabo C; Salazar M; Candelario-McKeown J; Athauda D; Zrinzo L; Akram H; Hariz M; Limousin P; Foltynie T
    Mov Disord; 2020 Jan; 35(1):101-108. PubMed ID: 31571270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of the emergence of apathy after bilateral stimulation of the subthalamic nucleus in patients with Parkinson's disease.
    Higuchi MA; Tsuboi Y; Inoue T; Fukuyama K; Abe H; Baba Y; Yamada T
    Neuromodulation; 2015 Feb; 18(2):113-7. PubMed ID: 24799286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinically-derived oscillatory biomarker predicts optimal subthalamic stimulation for Parkinson's disease.
    Rao AT; Lu CW; Askari A; Malaga KA; Chou KL; Patil PG
    J Neural Eng; 2022 Mar; 19(2):. PubMed ID: 35272281
    [No Abstract]   [Full Text] [Related]  

  • 40. Fusion image-based programming after subthalamic nucleus deep brain stimulation.
    Paek SH; Kim HJ; Yoon JY; Heo JH; Kim C; Kim MR; Lim YH; Kim KR; Kim JW; Han JH; Kim DG; Jeon BS
    World Neurosurg; 2011; 75(3-4):517-24. PubMed ID: 21600506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.